Design Therapeutics Stock Forecast, Price & News

-2.17 (-8.59 %)
(As of 04/13/2021 12:00 AM ET)
Today's Range
Now: $23.10
50-Day Range N/A
52-Week Range
Now: $23.10
Volume244,925 shs
Average Volume308,059 shs
Market Capitalization$1.24 billion
P/E RatioN/A
Dividend YieldN/A
There is no company description available for Design Therapeutics Inc.

Industry, Sector and Symbol

Industry --
Current SymbolNASDAQ:DSGN
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Market Cap$1.24 billion
Next Earnings DateN/A
OptionableNot Optionable


Design Therapeutics (NASDAQ:DSGN) Trading Down 9.4%
April 12, 2021 |
Design Therapeutics Inc
March 31, 2021 |
See More Headlines


Overall MarketRank

0.00 out of 5 stars

-- Sector

221st out of 266 stocks

-- Industry

223rd out of 268 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
-2.17 (-8.59 %)
(As of 04/13/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DSGN News and Ratings via Email

Sign-up to receive the latest news and ratings for DSGN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Design Therapeutics (NASDAQ:DSGN) Frequently Asked Questions

What stocks does MarketBeat like better than Design Therapeutics?

Wall Street analysts have given Design Therapeutics a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Design Therapeutics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Design Therapeutics' key competitors?

When did Design Therapeutics IPO?

(DSGN) raised $228 million in an initial public offering on Friday, March 26th 2021. The company issued 12,000,000 shares at $18.00-$20.00 per share. Goldman Sachs, SVB Leerink and Piper Sandler served as the underwriters for the IPO.

What is Design Therapeutics' stock symbol?

Design Therapeutics trades on the NASDAQ under the ticker symbol "DSGN."

When does the company's quiet period expire?

Design Therapeutics' quiet period expires on Wednesday, May 5th. Design Therapeutics had issued 12,000,000 shares in its initial public offering on March 26th. The total size of the offering was $240,000,000 based on an initial share price of $20.00. During the company's quiet period, insiders and underwriters that worked on the IPO are restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

How do I buy shares of Design Therapeutics?

Shares of DSGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Design Therapeutics' stock price today?

One share of DSGN stock can currently be purchased for approximately $23.10.

How much money does Design Therapeutics make?

Design Therapeutics has a market capitalization of $1.24 billion.

This page was last updated on 4/13/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.